about us

BFDA Benin is established to create and sustain a Regulatory control of imported food and drug into Benin Republic .
BFDA exists as an integral part of the Ministry of Health in Benin to protect public health by assuring the safety, efficacy and security of human and veterinary drugs, food, biological products, cosmetics, medical devices, household chemical substances, tobacco, household equipment and the conduct of clinical trials in the country.
Quality Policy
We will continually ensure quality, safe and efficacious / effective / wholesome products through Registration, Inspections, Licensing, Surveillance and Clinical Trials activities in conformity with the applicable national and international standards and to meet the National Regulatory Body responsible for the regulation of food, drugs, food supplements, herbal and homeopathic medicines, veterinary medicines, cosmetics, medical devices, household chemical substances, tobacco and tobacco products and the conduct of clinical trials.
BFDA was established in 1981 by the National Parliament of Benin under the revised Regulatory Products Legislation and integrated into a new Public Health Law 851, 2018 that gave birth to BFDA.
BFDA legal mandate is found in part 6 (Tobacco Control Measures), part 7 (organization and responsibilities of the BFDA), and part 8 (Clinical trials) of the Public Health Law, 2018 Section 851.
The Public Health Law provides for the establishment of a governing board with the responsibility of ensuring the effective implementation of the functions of the Agency.
BFDA currently has eleven-member Management Board. Administratively, the Agency is headed by the Director General who reports directly to the Management Board. The Chief Executive Officer of the BFDA takes responsibility for the daily operational management, service delivery and strategic issues of the Agency.
FDA has four (4) technical advisory committees (TAC) for safety of medicines, safety of vaccines and biological products, medical devices and clinical trials. The committees are made up of experts from different scientific backgrounds. The TAC on safety was formed to act as a forum to advise the Agency on matters relating to post-approval safety, efficacy, and effectiveness of the products granted marketing authorization by the Agency. The TAC for clinical trials also advises the BFDA on matters related to the conduct of clinical trials. The TAC provides expertise to assist the Agency in making appropriate risk management decisions, however, the decision making responsibility remains with the BFDA Benin

Our Mission

The mission of the Food and Drug Administration (FDA) of the Republic of Benin is to protect and promote public health by ensuring that all regulated products—including food, medicines, vaccines, medical devices, cosmetics, and other health-related commodities—are safe, effective, and of assured quality.

We are committed to implementing a science-based, transparent, and efficient regulatory system that safeguards consumers while fostering responsible industry growth and innovation. Through rigorous evaluation, licensing, inspection, laboratory testing, and post-market surveillance, we ensure that products entering and circulating within the national market comply with established legal and technical standards.

Our mission is carried out through the following key commitments:

1. Protection of Public Health
We prioritize the health and safety of citizens by preventing the distribution of counterfeit, substandard, contaminated, or unsafe products. We take decisive regulatory action to mitigate risks and respond swiftly to public health threats.

2. Science-Based Regulation
Our regulatory decisions are grounded in scientific evidence, risk assessment, and international best practices. We continuously strengthen our technical expertise to ensure credible and defensible decision-making.

3. Quality Assurance and Compliance
We establish and enforce standards for manufacturing, importation, storage, distribution, and marketing of regulated products. Through inspections and compliance monitoring, we promote adherence to Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), and food safety standards.

4. Post-Market Surveillance and Pharmacovigilance
We actively monitor products after market authorization to detect adverse drug reactions, safety concerns, and quality defects. This ensures ongoing protection of consumers and timely corrective actions when necessary.

5. Transparency and Accountability
We operate with integrity, fairness, and openness. Our regulatory processes are clear, predictable, and accessible to stakeholders, fostering public trust and confidence in our decisions.

6. Collaboration and Harmonization
We work closely with national stakeholders and international partners, including the World Health Organization, the West African Health Organization, and the Economic Community of West African States, to strengthen regulatory harmonization and capacity development across the region.

7. Support for Responsible Industry Development
While maintaining strict regulatory oversight, we provide guidance and support to manufacturers, importers, and distributors to encourage compliance, innovation, and sustainable growth within the health and food sectors.

Through these commitments, the Food and Drug Administration of the Republic of Benin strives to build a robust regulatory environment that protects citizens, enhances public confidence, and contributes to national development.

Our Core Values

88888

At the Food and Drug Administration (FDA) of the Republic of Benin, our work is guided by strong institutional values that shape our decisions, actions, and relationships with the public, industry, and partners. These core values define who we are and how we fulfill our mandate to protect public health.


1. Integrity

We uphold the highest ethical standards in all our operations.
Our regulatory decisions are made independently, impartially, and free from undue influence. We promote honesty, fairness, and professionalism in every aspect of our work, ensuring that public health interests always come first.

We maintain zero tolerance for corruption and misconduct, and we foster a culture of accountability and ethical responsibility among all staff.


2. Scientific Excellence

Our regulatory actions are grounded in science, evidence, and risk-based assessment.
We are committed to continuous learning, research, and adoption of international best practices to ensure that our evaluations and decisions are credible, transparent, and technically sound.

We strive to strengthen our scientific capacity and laboratory systems to meet evolving public health challenges.


3. Transparency

We conduct our regulatory processes in an open and clear manner.
Policies, procedures, requirements, and decisions are communicated effectively to stakeholders to promote understanding and compliance.

We believe that transparency builds public trust and enhances cooperation between regulators, industry, and consumers.


4. Accountability

We accept responsibility for our decisions and actions.
We operate within the framework of national laws and regulations and are committed to measurable performance, timely service delivery, and responsible governance.

We continuously evaluate our performance to ensure efficiency, effectiveness, and public confidence.


5. Public Protection

The health and safety of the people of Benin remain our highest priority.
Every regulatory action we take is guided by our duty to prevent harm, reduce risk, and ensure that only safe, effective, and quality products are available in the marketplace.

We act decisively against counterfeit, substandard, and unsafe products.


6. Professionalism

We maintain high standards of competence, respect, and service excellence.
Our staff are dedicated to carrying out their duties with diligence, objectivity, and respect for stakeholders.

We promote teamwork, continuous training, and professional development.


7. Collaboration

We recognize that effective regulation requires strong partnerships.
We work closely with government agencies, healthcare professionals, industry stakeholders, civil society, and international organizations such as the World Health Organization and the West African Health Organization to strengthen regulatory systems and protect public health across the region.


8. Innovation and Continuous Improvement

We are committed to modernizing our regulatory systems through technology, digital transformation, and process improvement.
We actively seek innovative approaches that enhance service delivery, improve surveillance systems, and strengthen regulatory efficiency.


9. Fairness and Equity

We treat all stakeholders fairly and without discrimination.
Our regulatory processes are consistent, predictable, and applied equally to all regulated entities, ensuring a level playing field while safeguarding consumer interests.

These core values define our institutional culture and guide our mission to serve and protect the people of the Republic of Benin. By upholding these principles, the Food and Drug Administration remains steadfast in its commitment to public health, transparency, and excellence in regulation.

quotes

“We have amazing team of hard working professionals. It has been a pleasure to meet them.”

Organizational Structure of BFDA Benin

99999

Governance and Leadership

The Food and Drug Administration (FDA) of the Republic of Benin operates under a structured governance framework designed to ensure accountability, transparency, and effective regulatory oversight.

The Agency functions under the supervision of the Government of Benin through the appropriate supervising Ministry responsible for public health. Strategic direction is provided at the executive level, while operational activities are managed through specialized directorates and technical units.


Office of the Director-General

The Director-General (DG) serves as the Chief Executive Officer of the Agency and is responsible for overall leadership, strategic planning, and regulatory decision-making.

Key Responsibilities:

  • Providing strategic direction and institutional leadership

  • Approving regulatory decisions and policies

  • Representing the Agency nationally and internationally

  • Ensuring compliance with national laws and international standards

  • Overseeing implementation of public health protection strategies

The Office of the Director-General is supported by Deputy Directors and senior advisors responsible for policy, legal affairs, and strategic partnerships.


Governing Board (Where Applicable)

The Governing Board provides policy guidance, oversight, and institutional accountability. It ensures that the Agency operates in alignment with national health priorities and regulatory mandates.

Core Functions of the Board:

  • Policy approval and strategic oversight

  • Financial and administrative supervision

  • Institutional performance monitoring


Core Directorates and Departments

The FDA operates through specialized technical and administrative directorates to effectively execute its mandate.


1. Directorate of Medicines and Vaccines Regulation

This directorate oversees the regulation of pharmaceuticals, biologicals, vaccines, and traditional medicines.

Functions:

  • Evaluation and registration of medicinal products

  • Clinical trial authorization and oversight

  • Good Manufacturing Practice (GMP) inspections

  • Pharmacovigilance coordination

  • Post-market surveillance of medicines


2. Directorate of Food Safety and Quality Control

Responsible for ensuring that food products meet national safety and quality standards.

Functions:

  • Registration and certification of food products

  • Food manufacturing facility inspections

  • Enforcement of food labeling regulations

  • Monitoring of imported and locally produced food

  • Management of food safety alerts and recalls


3. Directorate of Medical Devices and Diagnostics

This unit regulates medical devices, in-vitro diagnostics, and related technologies.

Functions:

  • Device classification and approval

  • Technical evaluation of device safety and performance

  • Market surveillance

  • Compliance inspections


4. Directorate of Cosmetics and Consumer Products

Responsible for regulating cosmetics and other consumer health products to ensure safety and compliance.

Functions:

  • Product notification and registration

  • Ingredient safety review

  • Market surveillance and enforcement


5. Inspectorate and Enforcement Division

This division ensures compliance with regulatory standards across all sectors.

Functions:

  • Routine and risk-based inspections

  • Investigation of regulatory violations

  • Market surveillance operations

  • Seizure and recall of unsafe products

  • Border and port inspections


6. Laboratory and Quality Control Services

The Agency operates accredited laboratories to support regulatory decisions through scientific testing.

Functions:

  • Laboratory testing of product samples

  • Quality verification

  • Support for enforcement actions

  • Technical analysis and research


7. Pharmacovigilance and Post-Market Surveillance Unit

This specialized unit monitors the safety of medicines and other regulated products after market approval.

Functions:

  • Monitoring adverse drug reactions

  • Risk assessment and signal detection

  • Safety communication and public alerts

  • Coordination with healthcare professionals


8. Licensing and Import/Export Control Department

Responsible for issuing operational licenses and regulating cross-border movement of regulated products.

Functions:

  • Licensing of manufacturers and distributors

  • Issuance of import and export permits

  • Border compliance verification

  • Documentation and clearance services


9. Legal Affairs and Regulatory Compliance Unit

Provides legal guidance and ensures enforcement actions align with national legislation.

Functions:

  • Legal advisory services

  • Drafting of regulations and guidelines

  • Handling disputes and sanctions

  • Representation in legal proceedings


10. Corporate Services Directorate

Supports the operational efficiency of the Agency.

Includes:

  • Human Resources

  • Finance and Accounts

  • Procurement and Logistics

  • Information Technology

  • Communications and Public Relations


Organizational Chart

The FDA operates under a hierarchical structure:

  • Governing Board

  • Director-General

    • Deputy Director-General(s)

      • Technical Directorates

      • Inspectorate & Enforcement

      • Laboratory Services

      • Licensing & Import/Export

      • Legal Affairs

      • Corporate Services


Regional and International Coordination

The Agency maintains coordination units that facilitate collaboration with regional and international partners such as:

  • World Health Organization

  • West African Health Organization

  • Economic Community of West African States

These partnerships strengthen regulatory harmonization and technical capacity.


Commitment to Effective Governance

The organizational structure of the Food and Drug Administration of the Republic of Benin is designed to ensure clear accountability, operational efficiency, scientific rigor, and responsive public health protection.

Through coordinated leadership and specialized expertise, the Agency continues to enhance regulatory performance and public confidence.

Scroll to Top